- Home
- A-Z Publications
- Current Topics in Medicinal Chemistry
- Previous Issues
- Volume 4, Issue 5, 2004
Current Topics in Medicinal Chemistry - Volume 4, Issue 5, 2004
Volume 4, Issue 5, 2004
-
-
PREFACE [Hot topic: Molecules of Infectious Agents as Immunomodulatory Drugs (Guest Editor: William Harnett)]
More LessMolecules of Infectious Agents as Immunomodulatory Drugs The continuous need to control infectious agents has invariably led to the application of emerging new biological disciplines and / or methodologies to their study. Particularly pertinent, advances in immunology and molecular biology during the first decades of the latter half of the twentieth century resulted in their application to research on infectious agents during th Read More
-
-
-
Molecules of Infectious Agents as Immunomodulatory Drugs
Authors: Ed C. Lavelle, Peter McGuirk and Kingston H.G. MillsMicrobes produce a wide range of molecules that can modulate eukaryotic immune responses. These include factors that subvert protective mechanisms in order to facilitate pathogen colonization and persistence. Viral, bacterial and parasite-derived molecules have been identified that can inhibit inflammatory responses. However, in addition to the plethora of microbial factors that suppress immune responses, the most Read More
-
-
-
Modulation of the Immune Response by the Cholera-like Enterotoxins
Authors: Andrea Plant and Neil A. WilliamsCholera toxins and heat labile enterotoxin from E. coli differ from most soluble proteins in eliciting systemic immunity both against themselves and unrelated admixed antigens, rather than tolerance following administration to a mucosal surface. Several reports have also demonstrated preferential induction of Th2-type responses when these molecules are used as adjuvants. Conversely, these proteins and their non-toxi Read More
-
-
-
The Impact of Infection on the Incidence of Autoimmune Disease
Authors: T. David C. Thomas, Paola Zaccone, David W. Dunne and Anne CookeFalling infection rates in the developed world are being matched by a rapidly rising incidence of allergic and autoimmune diseases. This review explores the hypothesis that there is a causal link between these phenomena and that infections can prevent the onset of autoimmune disease. The hypothesis is discussed with particular reference to Type I diabetes in the NOD mouse and the ability of the helminth infection Schist Read More
-
-
-
Th1-mediated Pathology in Mouse Models of Human Disease is Ameliorated by Concurrent Th2 Responses to Parasite Antigens
Authors: Mark T. Whary and James G. FoxEpidemiologic evidence strongly suggests that improved standards of living are associated with an increased incidence of immune system-mediated disease. Allergy, autoimmunity, and within the focus of our laboratory, idiopathic inflammatory bowel disease, most notably Crohn's disease and ulcerative colitis, and progression of chronic gastritis to gastric cancer, are all mediated by proinflammatory immune respo Read More
-
-
-
Molecules of Parasites as Immunomodulatory Drugs
Authors: Shinjiro Imai and Koichiro FujitaParasite molecules offer unique advantages for the treatment of immunologicical disorders, and several candidate molecules have been shown to be effective. In our studies, it was shown that a factor inducing immunoglobulin E from filarial nematode parasites was suppressive in animal models of immunological disorders such as allergy and insulin dependent diabetes mellitus (IDDM). The Th1 / /Th2 paradigm of CD4+ T Read More
-
-
-
The Anti-inflammatory Potential of the Filarial Nematode Secreted Product, ES-62
Authors: William Harnett, Margaret M. Harnett, Bernard P. Leung, Alastair Gracie and Iain B. McInnesFilarial nematodes achieve long-term infection via modulation of the host immune system. Although human infection can result in severe pathology, the majority of infected individuals exhibit little evidence of this. Analysis of the immune response during infection indicates that the apparently healthy majority have an anti-inflammatory phenotype and it has been speculated that this may contribute to maintenance o Read More
-
-
-
NKT Cell-Stimulating Synthetic Glycolipids as Potential Therapeutics for Autoimmune Disease
Authors: Takashi Yamamura, Katsuichi Miyamoto, Zsolt Illes, Endre Pal, Manabu Araki and Sachiko MiyakeAlthough T cells were previously believed to recognize only peptide antigen associated with the major histocompatibility complex (MHC), recent studies have shown that there are unique T cells specialized for recognition of lipid or glycolipid antigens bound to the MHC class I-like CD1 molecules (CD1a, b, c or d). Among these lipid-specific T cells, CD1d-restricted T cells, also referred to as natural killer (NK) T cells, are o Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/ctmc
Journal
10
5
false
en
